PDG correction revises disintegration-apparatus details for Japanese Pharmacopoeia
PMDA posted Q-02 Rev.2 Corr.1, correcting hole arrangement and sieve descriptions; Japanese implementation is planned for October 2027.
PMDA posted the Pharmacopoeial Discussion Group harmonised document Q-02 Rev.2 Corr.1 for the disintegration test. The correction concerns descriptions of the apparatus used for tablets and capsules, including hole placement and the sieve.
The correction is not yet an immediately effective change to the Japanese Pharmacopoeia. Implementation in Japan is planned for October 2027. Laboratories should check the official correction and the eventual Japanese text before updating apparatus specifications or procedures.